GB Sciences Inc.
Rank 130
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
$0.0331
USD
-5.30%
Market cap
$8,851,878
Total volume
$3,619
Shares outstanding
267,428,352
Reserved shares
332,571,648
Rank 130
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
GBLX |
$3,619
|
100% |
$0.0331
|
Chart